Home/Vaderis Therapeutics/Darryl Sleep, MD

DS

Darryl Sleep, MD

Chief Medical Officer

Vaderis Therapeutics

Therapeutic Areas

Rare Vascular Diseases Hereditary Hemorrhagic Telangiectasia (HHT)

Vaderis Therapeutics Pipeline

Drug	Indication	Phase
Engasertib	Hereditary Hemorrhagic Telangiectasia (HHT)	Pre-clinical

Leadership Team at Vaderis Therapeutics

Azmi Nabulsi, MD, MPH

President & CEO

Damien Picard, MD, PhD

Senior Medical Director & Co-Founder

Pierre Saint-Mezard, PhD, MBA

Chief Scientific Officer & Co-Founder

Chief Operating & Development Officer

View full Vaderis Therapeutics profile